tirzepatide for heart health Can tirzepatide, a long-acting agonist of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptors, provide effective treatment patients with failure and a preserved ejection fraction who also have obesity? ⁣ ⁣ Semaglutide and tirzepatide significantly improve

GLP-1 receptor agonists appear to shift immune activity from inflammatory to regulatory without compromising protective immunity

If youve started GLP1 therapy and feel better, this may be part of the reason

In an in-vivo study, prophylactic use of melatonin before myocardial ischemia-reperfusion surgery significantly improved cardiac function, reduced oxidative damage, and decreased myocardial apoptosis [24]

Neuroinflammation in ME/CFS was initially suggested by studies showing elevated levels of pro-inflammatory cytokines, and decreased anti-inflammatory cytokines, in cerebrospinal fluid from lumbar punctures in ME/CFS patients [62, 63], and further supported by a positron emission tomography (PET) study [64], which showed increased binding of a radioligand to 18 kDa translocator protein (TSPO) receptor, the expression of which increases when microglia are activated

It plays a vital role in managing blood sugar levels and, crucially for weight management, regulating appetite